scispace - formally typeset
L

Laura M. Raffield

Researcher at University of North Carolina at Chapel Hill

Publications -  179
Citations -  4816

Laura M. Raffield is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Genome-wide association study & Medicine. The author has an hindex of 23, co-authored 124 publications receiving 1948 citations. Previous affiliations of Laura M. Raffield include Medical University of South Carolina & Wake Forest University.

Papers
More filters
Journal ArticleDOI

Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND

TL;DR: In EAs with mild CKD enriched for T2D, brain structure and cognitive performance were generally not impacted and longitudinal studies are necessary to determine when cerebral structural changes and cognitive dysfunction develop with progressive CKD in EAs.
Journal ArticleDOI

Genetic determinants of telomere length from 109,122 ancestrally diverse whole-genome sequences in TOPMed

Margaret A. Taub, +146 more
- 01 Jan 2022 - 
TL;DR: This article reported the first sequencing-based association study for TL across ancestrally-diverse individuals (European, African, Asian and Hispanic/Latino) from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program.
Posted ContentDOI

Inherited Causes of Clonal Hematopoiesis of Indeterminate Potential in TOPMed Whole Genomes

Alexander G. Bick, +122 more
- 27 Sep 2019 - 
TL;DR: Overall, it is observed that germline genetic variation altering hematopoietic stem cell function and the fidelity of DNA-damage repair increase the likelihood of somatic mutations leading to CHIP.
Journal ArticleDOI

Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program.

Yao Hu, +84 more
TL;DR: In this paper, the authors leveraged whole-genome sequencing (WGS) data in up to 62,653 ethnically diverse participants from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program and assessed statistical association of variants with seven red blood cell (RBC) quantitative traits.